AVENTURA, Fla., Dec. 20, 2011 /PRNewswire/ -- Double Eagle Holdings, Ltd. (OTCQB: DROP), the parent company of Fuse Science, Inc. (www.fusescience.com), announced today the formal launch of its Hypoglycemic, Hyperglycemic, and Analgesic project platforms for the advancement of its OTC and pharmaceutical licensing efforts.
Some of the proprietary science platforms that Fuse Science deals with are oral fuse delivery technologies (OFD's). These OFD's are placed under the tongue or in the inner cheek of the patient where they are absorbed and release the applicable active or nutrient into the blood stream. OFD's do not require water and may be more convenient to take than liquids or injections. OFD's are especially designed to be very useful with pediatric and geriatric patients or anyone in need of faster absorption of a given active into the blood stream that bypasses the GI track, providing an alternative to the more traditional invasive drug delivery systems.
"Today we announce the further advancement of the true core of our Powered by Fuse™ technology," said Brian Tuffin, Fuse Science Chief Executive Officer. "It is with high confidence that we advance our OFD Analgesic, Hypoglycemic and Hyperglycemic project platforms with the objective of completing our pediatric and adult formulations to provide an effective sublingual and/or Buccal delivery alternative for the respective drugs."
The business opportunities from these project platforms are as follows:
"We are extremely passionate about our work in this area," said Ed Maliski, Ph.D. & Lead scientist. "Our work is born out of diabetes sufferers on staff who are committed to advancing these platforms with sense of urgency. We have produced significant results with our OFD work and feel very confident at this stage with our ability to advance these project platforms."
"We continue to be very deliberate and focused with every step we take as a company and our efforts in the OTC and Pharmaceutical space represents the foundation to our long term focus," added Tuffin. "These actions in combination with the with the long awaited, Powered by Fuse™ EnerJel™ launch on December 30th, 2011 at www.poweredbyfuse.com are calculated steps in our effort to create long term shareholder value."
About Double Eagle Holdings
Double Eagle Holdings (OTCQB: DROP) is the parent company of Fuse Science, Inc., an innovative consumer products holding company based in Aventura, Florida. The corporate name, Double Eagle Holdings is in the process of being changed to Fuse Science Inc. Fuse Science is the developer of new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The company has successfully developed and maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly – all in a concentrated "DROP" form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com or by calling 305-503-FUSE (3873).
Safe Harbor Statement: Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.
|SOURCE Double Eagle Holdings|
Copyright©2010 PR Newswire.
All rights reserved